A full list of RIETE investigators is given in the appendix.
D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE Registry
Article first published online: 19 AUG 2009
© 2009 International Society on Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis
Volume 7, Issue 11, pages 1795–1801, November 2009
How to Cite
LOBO, J. L., ZORRILLA, V., AIZPURU, F., GRAU, E., JIMÉNEZ, D., PALARETI, G., MONREAL, M. and THE RIETE INVESTIGATORS (2009), D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE Registry. Journal of Thrombosis and Haemostasis, 7: 1795–1801. doi: 10.1111/j.1538-7836.2009.03576.x
- Issue published online: 21 OCT 2009
- Article first published online: 19 AUG 2009
- Received 29 April 2009, accepted 6 August 2009
Summary. Background: A number of variables have been evaluated for risk stratification in patients with acute pulmonary embolism (PE). Whereas increased D-dimer levels have been associated with mortality at 3 months, its role in predicting short-term outcome (the period of time during which any therapeutic decision has to be taken) remains unclear. Methods: RIETE is an ongoing, prospective registry of consecutive patients with acute venous thromboembolism. We assessed the prognostic value of D-dimer levels at baseline, measured with an automated latex agglutination test (IL Test D-dimer®), on the 15-day outcome in patients with acute PE. Overall mortality, fatal PE and major bleeding rates were compared by quartile. Results: As of February 2008, 1707 patients with acute PE underwent D-dimer testing. Of these, 72 patients (4.2%) died during the first 15 days, 11 (0.6%) had recurrent PE, and 29 (1.7%) had major bleeding. Overall mortality increased with increasing D-dimer levels, from 2.7% in the first quartile (< 1050 ng mL−1) to 7.0% in the fourth quartile (≥ 4200 ng mL−1). The rates of fatal PE and major bleeding also increased. On multivariate analysis, patients with D-dimer levels in the fourth quartile had an increased risk for overall death (odds ratio, 1.8; 95% CI, 1.1–3.2), fatal PE (odds ratio, 2.0; 95% CI, 1.0–3.8) or major bleeding (odds ratio, 3.2; 95% CI, 1.5–7.0). Conclusions: PE patients with D-dimer levels in the fourth quartile had an increased incidence of overall death, fatal PE and major bleeding within 15 days both before and after multivariate adjustment.